News

Soleno Therapeutics Presents Updated Safety and Efficacy Data from Clinical Trial of DCCR for Treatment of Prader-Willi Syndrome

September 15, 2017

Updated Data Highlighted in Poster Presentation at 10 th International Meeting of Pediatric Endocrinology Phase III ...

Read More

Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR in Treatment of Prader-Willi Syndrome

September 13, 2017

Protection of Associated Claims into 2035 REDWOOD CITY, Calif. , Sept. 13, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (...

Read More

Soleno Therapeutics Announces CFO Transition

September 05, 2017

David O’Toole to Depart Company ; Interim CFO Appointed and Search for New CFO Initiated ...

Read More
Soleno – Home